Search | IOVS | ARVO Journals

Showing 1 – 18 of 18

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Clinical Outcomes of a Phone Call in Lieu of Day One Exam Following Uncomplicated 25-Gauge Vitrectomy Surgery

Jeffrey Lynn Tapley; John Mason

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5766. doi:

ARVO Annual Meeting Abstract June 2015

Clearance of disbetic vitreous hemorrhage with and without intravitreous bevicizumab

Richard M Feist; Bradley R. Langston; Claudia Ayala; Richard M. Feist; Carrie E Huisingh; John O Mason; michael A. Albert; Martin L Thomley; Deepthi M Reddy

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1742. doi:

ARVO Annual Meeting Abstract June 2015

Effect of Initial Visual Acuity on Cost of Diabetic Macular Edema Treatment

Deepthi M Reddy; Richard M Feist; Richard M. Feist; John O Mason; michael A. Albert; Martin L Thomley; Claudia Ayala

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2144. doi:

ARVO Annual Meeting Abstract April 2014

Optical Coherence Tomography Findings in Retinal Artery Occlusion

Richard M Feist; John O Mason; Martin L Thomley; Michael A Albert; Claudia M Ayala

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3390. doi:

ARVO Annual Meeting Abstract April 2014

Evolving Visual Results and Cost in Diabetic Macular Edema Treatment

Richard M Feist; Deepthi M Reddy; Richard M Feist; John O Mason; Martin L Thomley; Michael A Albert; Carrie E Huisingh; Natalie Price

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1752. doi:

ARVO Annual Meeting Abstract April 2014

Evaluation of Anti-VEGF Treatment in Peripapillary Neovascular Membranes

Richard Arceneaux; Frank Venzara; Martin L Thomley; Richard M Feist; Michael A Albert; John O Mason

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4933. doi:

ARVO Annual Meeting Abstract April 2014

Choroidal Melanoma Biopsy During Brachytherapy Using 25-Gauge Vitrectomy Technique: Clinical Experience

Deepthi M Reddy; Mohammed Naseemuddin; John O Mason; Jacob J Yunker; Duncan A Friedman

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2327. doi:

ARVO Annual Meeting Abstract April 2014

Safety and Efficacy of 25-Gauge Sutureless Vitrectomy for Idiopathic Macular Pucker

John O Mason; Nathan Wilbanks; Frank Venzara; Shawn Agee; Richard M Feist; Martin L Thomley; Michael A Albert

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1171. doi:

ARVO Annual Meeting Abstract June 2013

Vitreoretinal Surgical Outcomes Performed by Supervised Retinal Fellows Versus Attending Faculty Surgeons

John Mason; John Mason; Gerald McGwin; Lauren Mason; Thomas Finley; Duncan Friedman; Dustin Pomerleau; Michael Albert; Richard Feist; Martin Thomley

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3303. doi:

ARVO Annual Meeting Abstract June 2013

Postoperative bacterial endophthalmitis: tap/inject versus sutureless vitrectomy

Thomas Lindquist; Lauren Mason; John Mason; John Mason; Gerald McGwin; Carrie Huisingh; Duncan Friedman; Robert Morris; Matthew Oltmanns; Amanda Dinsmore

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3173. doi:

ARVO Annual Meeting Abstract June 2013

Comparison of outcomes after switching treatment from intravitreal bevacizumab or ranibizumab to aflibercept in neovascular age-related macular degeneration

Frank Venzara; John Mason; Jay Glover; Gerald McGwin; Carrie Huisingh; Duncan Friedman; Richard Feist; Martin Thomley; Michael Albert; Natalie Price

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3801. doi:

ARVO Annual Meeting Abstract March 2012

Sutureless Small Gauge Vitrectomy for Relief of Symptomatic Vitreous Floaters

John O. Mason, III; Michael G. Neimkin; John O. Mason, IV; Tracy L. Emond; Richard M. Feist; Martin L. Thomley; Michael A. Albert, Jr.; Jacob J. Yunker

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2751. doi:

ARVO Annual Meeting Abstract March 2012

Bacterial Susceptibility Profiles in Trauma Associated Endophthalmitis

Duncan A. Friedman; Mark L. Hill; Sejal Amin; Andrew Bartlett; Richard M. Feist; John O. Mason, III; Martin L. Thomley; Michael A. Albert, Jr.; Jacob J. Yunker; Tracy L. Emond

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1675. doi:

Retinal Cell Biology September 2011

The Influence of Alloxan-Induced Diabetes on Müller Cell Contraction-Promoting Activities in Vitreous

PDF

Jeffery L. King; John O. Mason, III; Samuel C. Cartner; Clyde Guidry
TAGS: alloxan, diabetes mellitus, vitreous body, suidae
Invest. Ophthalmol. Vis. Sci.. 2011; 52(10):7485-7491. doi: https://doi.org/10.1167/iovs.11-7781

ARVO Annual Meeting Abstract April 2011

Non-Supine Positioning is Preferred Over Face-Down Positioning and Provides an Equivalent Closure Rate in 25 and 23 gauge Macular Hole Surgery

Christopher J. Compton; Dusty L. Pomerleau; Richard M. Feist, Jr.; Lindsey R. Wallace; Richard M. Feist, Sr.; Tracy L. Emond; John O. Mason, III; Martin L. Thomley; Michael A. Albert

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4487. doi:

ARVO Annual Meeting Abstract April 2011

Preoperative and Intraoperative Administration of Intravitreal Avastin Only Transiently Inhibits Worsening of Diabetic Macular Edema Following Cataract Extraction

Joshua A. Hicks; Richard M. Feist, Jr.; Richard M. Feist, Sr.; Dustin L. Pomerleau; Tracy L. Emond; Lindsey R. Wallace; John O. Mason, III; Martin L. Thomley; Michael A. Albert, Jr.

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):557. doi:

ARVO Annual Meeting Abstract April 2011

Potential for Iatrogenic Contamination of Sterile Conditions During Intravitreal Injection

Duncan A. Friedman; John O. Mason, III; Tracy L. Emond; Lindsey R. Wallace

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1695. doi:

Retinal Cell Biology April 2009

Fibrocontractive Müller Cell Phenotypes in Proliferative Diabetic Retinopathy

PDF

Clyde Guidry; Jeffery L. King; John O. Mason, III
TAGS: antibodies, glial fibrillary acidic protein, glutamate-ammonia ligase, phenotype, proliferative diabetic retinopathy, vimentin, fluorescent antibody technique, glucose, culture media, suidae
Invest. Ophthalmol. Vis. Sci.. 2009; 50(4):1929-1939. doi: https://doi.org/10.1167/iovs.08-2475

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Clinical Outcomes of a Phone Call in Lieu of Day One Exam Following Uncomplicated 25-Gauge Vitrectomy Surgery

Clearance of disbetic vitreous hemorrhage with and without intravitreous bevicizumab

Effect of Initial Visual Acuity on Cost of Diabetic Macular Edema Treatment

Optical Coherence Tomography Findings in Retinal Artery Occlusion

Evolving Visual Results and Cost in Diabetic Macular Edema Treatment

Evaluation of Anti-VEGF Treatment in Peripapillary Neovascular Membranes

Choroidal Melanoma Biopsy During Brachytherapy Using 25-Gauge Vitrectomy Technique: Clinical Experience

Safety and Efficacy of 25-Gauge Sutureless Vitrectomy for Idiopathic Macular Pucker

Vitreoretinal Surgical Outcomes Performed by Supervised Retinal Fellows Versus Attending Faculty Surgeons

Postoperative bacterial endophthalmitis: tap/inject versus sutureless vitrectomy

Comparison of outcomes after switching treatment from intravitreal bevacizumab or ranibizumab to aflibercept in neovascular age-related macular degeneration

Sutureless Small Gauge Vitrectomy for Relief of Symptomatic Vitreous Floaters

Bacterial Susceptibility Profiles in Trauma Associated Endophthalmitis

The Influence of Alloxan-Induced Diabetes on Müller Cell Contraction-Promoting Activities in Vitreous

Non-Supine Positioning is Preferred Over Face-Down Positioning and Provides an Equivalent Closure Rate in 25 and 23 gauge Macular Hole Surgery

Preoperative and Intraoperative Administration of Intravitreal Avastin Only Transiently Inhibits Worsening of Diabetic Macular Edema Following Cataract Extraction

Potential for Iatrogenic Contamination of Sterile Conditions During Intravitreal Injection

Fibrocontractive Müller Cell Phenotypes in Proliferative Diabetic Retinopathy

To View More...

You must be signed into an individual account to use this feature.